Skip to main content

SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

Deliverables

Searching for OpenAIRE data...

Publications

Acute-on-chronic liver failure: an update

Author(s): Ruben Hernaez, Elsa Solà, Richard Moreau, Pere Ginès
Published in: Gut, Issue 66/3, 2017, Page(s) 541-553, ISSN 0017-5749
DOI: 10.1136/gutjnl-2016-312670

Hepatorenal syndrome in the era of acute kidney injury

Author(s): Cristina Solé, Elisa Pose, Elsa Solà, Pere Ginès
Published in: Liver International, 2018, ISSN 1478-3223
DOI: 10.1111/liv.13893

Statins: old drugs as new therapy for liver diseases?

Author(s): Elisa Pose, Jonel Trebicka, Rajeshwar P. Mookerjee, Paolo Angeli, Pere Ginès
Published in: Journal of Hepatology, 2018, ISSN 0168-8278
DOI: 10.1016/j.jhep.2018.07.019

More Than Meets the Eye in Using Interleukin 6 as a Marker of Inflammation and Prognostic Factor for Patients With Cirrhosis

Author(s): Pere Ginès, Shiv Sarin
Published in: Clinical Gastroenterology and Hepatology, Issue 16/5, 2018, Page(s) 630-632, ISSN 1542-3565
DOI: 10.1016/j.cgh.2017.12.031

Nursing care of patients with cirrhosis


Published in: ISSN 0270-9139
DOI: 10.1002/hep.31117

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival

Author(s): Cristina Solé, Elsa Solà, Patricia Huelin, Marta Carol, Rebeca Moreira, Unai Cereijo, José‐Manuel Mas, Isabel Graupera, Elisa Pose, Laura Napoleone, Gloria dePrada, Adrià Juanola, Núria Fabrellas, Ferran Torres, Manuel Morales‐Ruiz, Judith Farrés, Wladimiro Jiménez, Pere Ginès
Published in: Liver International, Issue 39/7, 2019, Page(s) 1246-1255, ISSN 1478-3223
DOI: 10.1111/liv.14037